Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 2529 entries
View as:

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT00426140 Org: User:
Start: 08/31/06 End: - Due: -

Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00418756 Org: User:
Start: 10/31/06 End: - Due: -

Retrospective Chart Review and Historical Comparison of Capmatinib vs. Standard of Care for German Adult Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring METex14 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05796726 Org: User:
Start: 12/10/21 End: 03/22/22 Due: 03/22/23

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Phase: N/A Priority: Normal
NCT ID: NCT01442194 Org: User:
Start: 08/01/11 End: 07/10/20 Due: 07/10/21

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01257815 Org: User:
Start: 01/31/11 End: 04/30/13 Due: 04/30/14

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT04632056 Org: User:
Start: 11/16/20 End: 11/10/22 Due: 11/10/23

Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01285492 Org: User:
Start: 01/31/11 End: 09/30/12 Due: 09/30/13

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01555151 Org: User:
Start: 07/31/12 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02267135 Org: User:
Start: 09/29/14 End: 12/07/15 Due: 12/07/16

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Phase: N/A Priority: Normal
NCT ID: NCT06784752 Org: User:
Start: 05/29/25 End: 01/05/34 Due: 01/05/35

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00239811 Org: User:
Start: 04/30/04 End: - Due: -

Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Phase: N/A Priority: Normal
NCT ID: NCT03242928 Org: User:
Start: 12/04/17 End: 12/16/19 Due: 12/16/20

Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.

Phase: N/A Priority: Normal
NCT ID: NCT06271369 Org: User:
Start: 08/11/22 End: 02/15/23 Due: 02/15/24

Phase III B in Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03123939 Org: User:
Start: 04/24/17 End: 10/13/20 Due: 10/13/21

Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01259492 Org: User:
Start: 11/30/10 End: 08/31/12 Due: 08/31/13

A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01911936 Org: User:
Start: 09/30/13 End: 03/31/15 Due: 03/31/16

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00794157 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02750592 Org: User:
Start: 03/22/16 End: 05/16/18 Due: 05/16/19

Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02970669 Org: User:
Start: 12/16/16 End: 03/19/18 Due: 03/19/19

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01569828 Org: User:
Start: 03/31/09 End: 09/30/09 Due: 09/30/10

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT05024058 Org: User:
Start: 11/16/21 End: 08/09/22 Due: 08/09/23

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT00961896 Org: User:
Start: 07/31/09 End: - Due: -

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03798626 Org: User:
Start: 05/22/19 End: 02/05/25 Due: 02/05/26

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Phase: N/A Priority: Normal
NCT ID: NCT03560739 Org: User:
Start: 09/11/18 End: 05/05/20 Due: 05/05/21

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT05360446 Org: User:
Start: 07/08/22 End: 01/25/27 Due: 01/25/28